Category: MOST POPULAR

Most Popular Blog Posts - Larger Font 720

FDAzilla’s Top 20 Posts of All Time

Over the years, the FDAzilla blog has published over 650 articles. We hope this compilation will serve as a resource for you and your company.  It should also help orient you to the scope of the FDAzilla blog as you continue to follow our efforts to provide accessible FDA data and insights.

Read More »
483 Cost

A Bad 483 Could Cost a Company Millions

I spoke to a former VP of quality at the PDA/FDA Joint Regulatory Conference. He said one of his bad 483s probably cost him $5 million. And that’s cheap – that’s just a 483. What about a warning letter? There is an even greater magnitude of reputation damage, impact on new drug approvals, etc. This post describes the full scope and includes articles/case studies.

Read More »
FSMA Has Arrived

FSMA Has Arrived – Here’s What We Know So Far

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_size=””

Read More »

Not Finding What You Are Looking For?

SEARCH OUR BLOG:

SEARCH OUR PRO KNOWLEDGE BASE:

CONTACT US:      844-332-3320 | info@fdazilla.com

Can’t find what you are looking for? Contact us.